Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Biotech
Moderna posts melanoma data behind decision to say 'I do' to IDO
Responses in melanoma patients failed by checkpoint inhibitors informed a decision to expand and prioritize development of the cancer candidate.
Nick Paul Taylor
Oct 13, 2025 5:15am
Fierce Pharma
ACIP narrowly votes against COVID vaccine prescriptions
Sep 19, 2025 5:22pm
Biotech veteran Robert Langer joins son launching new VC
Sep 18, 2025 3:15pm
Carisma's lifeline disappears as reverse merger plans break down
Sep 18, 2025 10:40am
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
Moderna flu vaccine beats approved competitor in fresh ph. 3 win
Jun 30, 2025 8:05am